BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18246121)

  • 21. The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms.
    Felicetti F; Errico MC; Bottero L; Segnalini P; Stoppacciaro A; Biffoni M; Felli N; Mattia G; Petrini M; Colombo MP; Peschle C; Carè A
    Cancer Res; 2008 Apr; 68(8):2745-54. PubMed ID: 18417445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spermatogonial stem cell self-renewal requires OCT4, a factor downregulated during retinoic acid-induced differentiation.
    Dann CT; Alvarado AL; Molyneux LA; Denard BS; Garbers DL; Porteus MH
    Stem Cells; 2008 Nov; 26(11):2928-37. PubMed ID: 18719224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The acute promyelocytic leukemia-associated protein, promyelocytic leukemia zinc finger, regulates 1,25-dihydroxyvitamin D(3)-induced monocytic differentiation of U937 cells through a physical interaction with vitamin D(3) receptor.
    Ward JO; McConnell MJ; Carlile GW; Pandolfi PP; Licht JD; Freedman LP
    Blood; 2001 Dec; 98(12):3290-300. PubMed ID: 11719366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The PLZF gene of t (11;17)-associated APL.
    McConnell MJ; Licht JD
    Curr Top Microbiol Immunol; 2007; 313():31-48. PubMed ID: 17217037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth suppression by acute promyelocytic leukemia-associated protein PLZF is mediated by repression of c-myc expression.
    McConnell MJ; Chevallier N; Berkofsky-Fessler W; Giltnane JM; Malani RB; Staudt LM; Licht JD
    Mol Cell Biol; 2003 Dec; 23(24):9375-88. PubMed ID: 14645547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study of dominant negative effect of the PLZF-RARalpha against the wild-type RARalpha in acute promyelocytic leukemia].
    Dong S; Zhu J; Kuang S; Qiu J; Wang Z; Chen S; Chen L
    Zhonghua Xue Ye Xue Za Zhi; 1997 Jan; 18(1):8-12. PubMed ID: 15622742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions of GATA-2 with the promyelocytic leukemia zinc finger (PLZF) protein, its homologue FAZF, and the t(11;17)-generated PLZF-retinoic acid receptor alpha oncoprotein.
    Tsuzuki S; Enver T
    Blood; 2002 May; 99(9):3404-10. PubMed ID: 11964310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinoblastoma protein and the leukemia-associated PLZF transcription factor interact to repress target gene promoters.
    Petrie K; Guidez F; Zhu J; Howell L; Owen G; Chew YP; Parks S; Waxman S; Licht J; Mittnacht S; Zelent A
    Oncogene; 2008 Sep; 27(39):5260-6. PubMed ID: 18504436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of apoptosis-related PLZF target genes.
    Bernardo MV; Yelo E; Gimeno L; Campillo JA; Parrado A
    Biochem Biophys Res Commun; 2007 Jul; 359(2):317-22. PubMed ID: 17537403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. KAP1-independent transcriptional repression of SCAN-KRAB-containing zinc finger proteins.
    Itokawa Y; Yanagawa T; Yamakawa H; Watanabe N; Koga H; Nagase T
    Biochem Biophys Res Commun; 2009 Oct; 388(4):689-94. PubMed ID: 19695231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human endogenous retrovirus protein cORF supports cell transformation and associates with the promyelocytic leukemia zinc finger protein.
    Boese A; Sauter M; Galli U; Best B; Herbst H; Mayer J; Kremmer E; Roemer K; Mueller-Lantzsch N
    Oncogene; 2000 Sep; 19(38):4328-36. PubMed ID: 10980608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation.
    Nasr R; Guillemin MC; Ferhi O; Soilihi H; Peres L; Berthier C; Rousselot P; Robledo-Sarmiento M; Lallemand-Breitenbach V; Gourmel B; Vitoux D; Pandolfi PP; Rochette-Egly C; Zhu J; de Thé H
    Nat Med; 2008 Dec; 14(12):1333-42. PubMed ID: 19029980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The promyelocytic leukemia zinc finger protein: two decades of molecular oncology.
    Suliman BA; Xu D; Williams BR
    Front Oncol; 2012; 2():74. PubMed ID: 22822476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. POZ for effect--POZ-ZF transcription factors in cancer and development.
    Kelly KF; Daniel JM
    Trends Cell Biol; 2006 Nov; 16(11):578-87. PubMed ID: 16996269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Promyelocytic Leukemia Zinc Finger (PLZF ) gene is a novel transcriptional target of the CCAAT-Displacement-protein (CUX1) repressor.
    Fréchette I; Darsigny M; Brochu-Gaudreau K; Jones C; Boudreau F
    FEBS J; 2010 Oct; 277(20):4241-53. PubMed ID: 20945532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deregulated expression of promyelocytic leukemia zinc finger protein in B-cell chronic lymphocytic leukemias does not affect cyclin A expression.
    Parrado A; Noguera ME; Delmer A; McKenna S; Davies J; Le Gall I; Bentley P; Whittaker JA; Sigaux F; Chomienne C; Padua RA
    Hematol J; 2000; 1(1):15-27. PubMed ID: 11920165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-32α modulates promyelocytic leukemia zinc finger gene activity by inhibiting protein kinase Cɛ-dependent sumoylation.
    Park YS; Kang JW; Lee DH; Kim MS; Bak Y; Yang Y; Lee HG; Hong J; Yoon DY
    Int J Biochem Cell Biol; 2014 Oct; 55():136-43. PubMed ID: 25178676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomic analysis of acute promyelocytic leukemia: PML-RARalpha leads to decreased phosphorylation of OP18 at serine 63.
    Zada AA; Geletu MH; Pulikkan JA; Müller-Tidow C; Reddy VA; Christopeit M; Hiddemann WD; Behre HM; Tenen DG; Behre G
    Proteomics; 2006 Nov; 6(21):5705-19. PubMed ID: 17001604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PLZF-mediated control on VLA-4 expression in normal and leukemic myeloid cells.
    Quaranta MT; Spinello I; Testa U; Mariani G; Diverio D; Foà R; Peschle C; Labbaye C
    Oncogene; 2006 Jan; 25(3):399-408. PubMed ID: 16158049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypermethylation reduces expression of tumor-suppressor PLZF and regulates proliferation and apoptosis in non-small-cell lung cancers.
    Wang X; Wang L; Guo S; Bao Y; Ma Y; Yan F; Xu K; Xu Z; Jin L; Lu D; Xu J; Wang JC
    FASEB J; 2013 Oct; 27(10):4194-203. PubMed ID: 23804241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.